Senzime AB Cash Flow Conversion Efficiency

Latest as of June 2026: -0.052x

Senzime AB cash flow conversion efficiency. Based on the latest financial reports, Senzime AB (SEZI) has a cash flow conversion efficiency ratio of -0.052x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-13.68 Million ≈ $-1.47 Million USD) by net assets (Skr263.84 Million ≈ $28.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Senzime AB (2006–2025)

Cash flow conversion efficiency of Senzime AB from 2006 to 2025. This chart illustrates how Senzime AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Senzime AB (SEZI) stock price for real-time trading data and today's change.

Senzime AB Cash Flow Conversion Ratio Explained

Senzime AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Senzime AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Senzime AB ranked by their cash flow conversion efficiency. Also see Senzime AB (SEZI) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Arlitech Electronic TWO:6432	0.043x
Hil Industries Bhd KLSE:8443	-0.027x
WPP PLC LSE:WPP	-0.304x
ADOLFO DOMINGUEZ MC:ADZ	0.253x
American Creek Resources Ltd V:AMK	-0.114x
Young Heung I& KO:012160	0.002x
Global View Co Ltd TW:3040	-0.005x
Icure Pharmaceutical Incorporation KQ:175250	-0.068x

Annual Cash Flow Conversion Efficiency for Senzime AB (2006–2025)

The table below shows the annual cash flow conversion efficiency of Senzime AB from 2006 to 2025. Review free cash flow generation of Senzime AB to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr304.46 Million ≈ $32.76 Million	Skr-109.10 Million ≈ $-11.74 Million	-0.358x	-16.98%
2024-12-31	Skr345.86 Million ≈ $37.22 Million	Skr-105.94 Million ≈ $-11.40 Million	-0.306x	-0.97%
2023-12-31	Skr375.48 Million ≈ $40.41 Million	Skr-113.91 Million ≈ $-12.26 Million	-0.303x	+41.91%
2022-12-31	Skr261.90 Million ≈ $28.18 Million	Skr-136.78 Million ≈ $-14.72 Million	-0.522x	+3.31%
2021-12-31	Skr150.58 Million ≈ $16.20 Million	Skr-81.33 Million ≈ $-8.75 Million	-0.540x	-225.94%
2020-12-31	Skr231.35 Million ≈ $24.90 Million	Skr-38.34 Million ≈ $-4.13 Million	-0.166x	+0.04%
2019-12-31	Skr163.69 Million ≈ $17.62 Million	Skr-27.14 Million ≈ $-2.92 Million	-0.166x	-56.49%
2018-12-31	Skr167.41 Million ≈ $18.02 Million	Skr-17.73 Million ≈ $-1.91 Million	-0.106x	-21.04%
2017-12-31	Skr140.46 Million ≈ $15.12 Million	Skr-12.29 Million ≈ $-1.32 Million	-0.088x	-15.36%
2016-12-31	Skr131.87 Million ≈ $14.19 Million	Skr-10.00 Million ≈ $-1.08 Million	-0.076x	+45.81%
2015-12-31	Skr45.81 Million ≈ $4.93 Million	Skr-6.41 Million ≈ $-690.18K	-0.140x	-60.40%
2014-12-31	Skr44.08 Million ≈ $4.74 Million	Skr-3.85 Million ≈ $-414.05K	-0.087x	+39.78%
2013-12-31	Skr37.46 Million ≈ $4.03 Million	Skr-5.43 Million ≈ $-584.31K	-0.145x	+23.55%
2012-12-31	Skr31.99 Million ≈ $3.44 Million	Skr-6.06 Million ≈ $-652.57K	-0.190x	-170.80%
2011-12-31	Skr27.87 Million ≈ $3.00 Million	Skr-1.95 Million ≈ $-209.94K	-0.070x	+27.67%
2010-12-31	Skr21.90 Million ≈ $2.36 Million	Skr-2.12 Million ≈ $-228.10K	-0.097x	-0.30%
2009-12-31	Skr16.61 Million ≈ $1.79 Million	Skr-1.60 Million ≈ $-172.54K	-0.096x	-664.63%
2006-12-31	Skr7.55 Million ≈ $812.29K	Skr129.00K ≈ $13.88K	0.017x	--

About Senzime AB

ST:SEZI Sweden Medical Devices

Market Cap

$54.99 Million

Skr510.95 Million SEK

Market Cap Rank

#21351 Global

#390 in Sweden

Share Price

Skr3.25

Change (1 day)

+3.83%

52-Week Range

Skr2.42 - Skr5.81

All Time High

Skr26.50